Maternal Grandmothers in the Born in Guangzhou Cohort Study (MGBIG)

September 11, 2023 updated by: Xiu Qiu, Guangzhou Women and Children's Medical Center
The MGBIG is a study exploring cross-generational effects in 5000 women and their children and grandchildren located in Guangzhou, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology and on explaining the cause of the disease from the perspective of "grandmother-mother-child" heredity. Data are collected regarding environmental exposures, lifestyle, and social support on grandmother from birth to old age. Biological samples including blood and tissue samples are collected.

Study Overview

Detailed Description

It was previously believed that heredity strictly follows Mendel's laws, but recent studies have found that through placental material exchange, mammals may transfer maternal immune-related factors vertically, thus promoting the protection of "non-heredited maternal antigenic traits". Thus, the transmission of reproductive information across generations is realized. Since the unusual genetic pattern of the X chromosome, grandmother's influence may be gender specific. Since grandchildren were usually took care by grandparents in China, it could be achievable to attach and recruit maternal grandmother together with mother and children. Cohort including three generations of women is rare in Asia at present. In the MGBIG, extensive information including demographic characteristics, lifestyle, history of diseases, mental health, and behaviors is collected from the participants. Longitudinal follow up and surveillance of common chronic diseases are also to be conducted. The MGBIG intends to recruit maternal grandmothers to study the effects of maternal genetic and environmental exposure on the health of their children and grandchildren.

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510623
        • Recruiting
        • Guangzhou Women and Children's Medical Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

36 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All maternal grandmothers of the children in the Born in Guangzhou Cohort Study (BIGCS) would be recruited.

Description

Inclusion Criteria:

  1. Maternal Grandmother' grandchildren delivered in Guangzhou Women and Children's Medical Center
  2. Baseline information of maternal grandmother's daughter during pregnancy available

Exclusion Criteria:

  1. Significant cardiovascular abnormalities
  2. Intelligent obstacle, intellectual disabilities or gawkish condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Haplotypes transfered by non-inherited maternal antigens from maternal grandmother to female offspring
Time Frame: From the date of her daughter get pregnant until the date her grandchild/grandchildren is/are given birth
Assessed by analyses of MHC haplotypes, HLA haplotypes, and levels of non-inherited maternal antigens of mother and offspring, and pregnancy complication of maternal grandmothers and mothers
From the date of her daughter get pregnant until the date her grandchild/grandchildren is/are given birth

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum levels of Inflammatory factors at grandchildren's birth and early neonatal life
Time Frame: At the birth date of her grandchild/grandchildren, at the date 42 days after the birth of the certain grandchild/grandchildren
Assessed by analyses of IL-1, IL-6, IL-10, IL-12, etc.
At the birth date of her grandchild/grandchildren, at the date 42 days after the birth of the certain grandchild/grandchildren
The prevalence of eczema of grandchildren
Time Frame: At the age of 6 weeks, 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
Assessed by self-reported time of onset and electronic medical record
At the age of 6 weeks, 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
The incidence of asthma of grandchildren
Time Frame: At the age of 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
Assessed by self-reported time of onset and electronic medical record
At the age of 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
The prevalence of Allergic rhinitis of grandchildren
Time Frame: At the age of 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
Assessed by self-reported time of onset and electronic medical record
At the age of 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
The prevalence of Food allergy of children and grandchildren
Time Frame: At the age of 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
Assessed by self-reported time of onset and electronic medical record
At the age of 6 months, 1year, 3 years, 6 years, 12years and 18years of grandchildren
Changes of body composition of grandchildren
Time Frame: At age of 3 years,6 years, 12years and 18years
Body composition is assessed using Dual Energy X-Ray Absorptiometry
At age of 3 years,6 years, 12years and 18years
Changes of bone density of grandchildren
Time Frame: At age of 3 years,6 years, 12years and 18years
Bone density is assessed using Dual Energy X-Ray Absorptiometry
At age of 3 years,6 years, 12years and 18years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xiu Qiu, PhD, Guangzhou Women and Children's Medical Center, China

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 21, 2018

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2038

Study Registration Dates

First Submitted

July 23, 2018

First Submitted That Met QC Criteria

August 13, 2018

First Posted (Actual)

August 16, 2018

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018041801
  • 81673181 (Other Grant/Funding Number: National Natural Science Foundation of China)
  • 201508030037 (Other Grant/Funding Number: Guangzhou Science and Technology Bureau, Guangzhou, China)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Childhood Obesity

3
Subscribe